NCOA3 and thyroid cancer, nonmedullary, 2: Quantitative analysis shows that 54.6% of ATC cells were positive for SRC-3 vs. only 18.6% of PTC cells, 13.9% of FTC cells, and 18.3% of normal thyroid cells [Figure 3A-III].